Human papillomavirus and prostate cancer: systematic review and meta-analysis
- PMID: 37789036
- PMCID: PMC10547781
- DOI: 10.1038/s41598-023-43767-7
Human papillomavirus and prostate cancer: systematic review and meta-analysis
Abstract
The involvement of human papillomavirus (HPV) in the prostate carcinogenesis is a controversial issue. The presented meta-analysis was carried out to systematize the currently available research results regarding this question. The meta-analysis includes case-control studies from 1991 to 2022, which were collected from publicly available bibliometric databases. The meta-analysis was performed using Meta-Essentials_1.5 software. We used Begg's and Egger's methods to assess publication bias. Cochran's Q test was used to assess heterogeneity and the I2 index was employed for calculating the variation in the pooled estimations. The analysis was based on data from 27 case-control studies, which in total yielded 1607 tumour tissue samples of prostate and 1515 control samples (317 samples of normal tissue, 1198 samples of benign prostatic hyperplasia (BPH)). According to the data obtained, there was high risk of prostate cancer by HPV infection in both cases. HPV was found in prostate cancer in 25.8% of cases, while in normal tissue samples the virus was detected in 9.2% of cases and in 17.4% with BPH as a control. In particular, more studies on the association of HPV and prostate cancer are needed to prove the role of HPV in the development of prostate cancer. In addition to the controversial question of whether HPV infection is associated with prostate cancer risk, it is worth considering whether the samples used as a control have an impact on the results. The impact of HPV in prostate tumour tissue samples on outcome should also be investigated.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients.Pathol Oncol Res. 2011 Sep;17(3):613-7. doi: 10.1007/s12253-010-9357-4. Epub 2011 Jan 16. Pathol Oncol Res. 2011. PMID: 21240663
-
Evaluation of human papillomavirus infections in prostatic disease: a cross-sectional study in Iran.Asian Pac J Cancer Prev. 2013;14(5):3305-8. doi: 10.7314/apjcp.2013.14.5.3305. Asian Pac J Cancer Prev. 2013. PMID: 23803120
-
The role of human papillomavirus infection in prostate carcinoma.Scand J Infect Dis. 2011 Jan;43(1):64-9. doi: 10.3109/00365548.2010.502904. Epub 2010 Jul 22. Scand J Infect Dis. 2011. PMID: 20662618
-
Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis.Asia Pac J Clin Oncol. 2019 Oct;15(5):e59-e67. doi: 10.1111/ajco.13124. Epub 2019 Feb 10. Asia Pac J Clin Oncol. 2019. PMID: 30740893
-
[MALIGNANT NEOPLASMS OF THE REPRODUCTIVE SYSTEM IN MEN AND THEIR CONNECTION WITH THE HUMAN PAPILLOMAVIRUS. (REVIEW)].Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024 Oct;32(Special Issue 2):1090-1093. doi: 10.32687/0869-866X-2024-32-s2-1090-1093. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024. PMID: 39530931 Review. Russian.
Cited by
-
The Recurrence of Tracheobronchial Papillomatosis Following Prostate Cancer Diagnosis.Cureus. 2024 Nov 25;16(11):e74450. doi: 10.7759/cureus.74450. eCollection 2024 Nov. Cureus. 2024. PMID: 39726495 Free PMC article.
-
Human papillomavirus and prostate cancer in Mexican men: a systematic review and meta-analysis.Cancer Causes Control. 2025 Aug;36(8):755-764. doi: 10.1007/s10552-025-01989-2. Epub 2025 Mar 15. Cancer Causes Control. 2025. PMID: 40088360
-
Current Trends and Challenges of Microbiome Research in Prostate Cancer.Curr Oncol Rep. 2024 May;26(5):477-487. doi: 10.1007/s11912-024-01520-x. Epub 2024 Apr 4. Curr Oncol Rep. 2024. PMID: 38573440 Review.
-
A review of the carcinogenic potential of human papillomavirus (HPV) in urological cancers.Virol J. 2025 Feb 28;22(1):53. doi: 10.1186/s12985-025-02682-1. Virol J. 2025. PMID: 40022189 Free PMC article. Review.
-
Rapid Lifestyle Recommendations to Improve Urologic, Heart and Overall Health.Curr Urol Rep. 2024 Oct 8;26(1):10. doi: 10.1007/s11934-024-01246-0. Curr Urol Rep. 2024. PMID: 39377857 Review.
References
-
- Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. - PubMed
-
- Gandaglia G, et al. Epidemiology and prevention of prostate cancer. Eur. Urol. Oncol. 2021;4:877–892. - PubMed
-
- Hemminki K. Familial risk and familial survival in prostate cancer. World J. Urol. 2012;30:143–148. - PubMed
-
- Bruner DW, et al. Relative risk of prostate cancer for men with affected relatives: Systematic review and meta-analysis. Int. J. Cancer. 2003;107:797–803. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical